Why Dan Loeb Just Made Kenvue One Of His Top Holdings

Zinger Key Points

Activist investor Dan Loeb‘s Third Point LLC acquired a significant stake in consumer health company Kenvue Inc. KVUE in the first quarter of 2025.

Kenvue was formerly a part of Johnson & Johnson JNJ before becoming an independent company in August 2023.

The company’s major products include several J&J brands, including Tylenol, Listerine, Neutrogena, and Nicorette

According to recent 13F filings, reflecting his holding as of March 31, 2025, Loeb bought an 8.9 million stake in the company, thereby placing it among his top five holdings.

Let's have a look at the company’s major events.

  • On May 8, the company reported first-quarter 2025 sales of $3.74 billion, beating the consensus of $3.68 billion.
  • Kenvue updated its fiscal 2025 outlook to reflect current foreign exchange rates and the estimated impact of higher costs due to tariffs
  • The company now expects a net sales increase of +1% to +3% (-1% to +1% prior) year-over-year, with organic sales growth of +2% to +4 (unchanged) and a ~1% headwind from foreign currency translation (earlier expected around 3%).
  • Also, Kenvue appointed Amit Banati as the company's CFO, effective May 12. Banati will succeed Paul Ruh.
  • On April 16, Kenvue announced a five-year collaboration with Microsoft Corporation MSFT to establish a strong foundation for transforming digital operations through advanced Artificial Intelligence (AI) technologies.
  • Kenvue shares rose nearly 11.5% year to date, compared to the Renaissance IPO ETF IPO, which fell about 1.36% over the same time frame.
  • The company’s shares also fared well compared to its closest peer, Estee Lauder Companies, Inc. EL, which declined 15.06% year to date.
Loading...
Loading...

Read Next:

Image created using artificial intelligence via Midjourney.

KVUE Logo
KVUEKenvue Inc
$21.460.77%

Stock Score Locked: Edge Members Only

Benzinga Rankings give you vital metrics on any stock – anytime.

Unlock Rankings
Edge Rankings
Momentum
68.45
Growth
Not Available
Quality
Not Available
Value
23.89
Price Trend
Short
Medium
Long
Market News and Data brought to you by Benzinga APIs

Comments
Loading...